Sahibzada Afzal MD is categorized under Internal Medicine Practitioners in Canoga Park, CA and active since 1974.
Sahibzada Afzal MD was established in 1974, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Afzal Sahibzada at the company’s single location by writing to 22110 Roscoe Boulevard # 301, Canoga Park, California CA 91304 or by phoning (818) 719-9117. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sahibzada Afzal MD |
| Contact Person: | Afzal Sahibzada |
| Address: | 22110 Roscoe Boulevard # 301, Canoga Park, California 91304 |
| Phone Number: | (818) 719-9117 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Sahibzada Afzal MD was started in 1974 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Afzal Sahibzada for inquiries that concern Sahibzada Afzal MD by calling the company number (818) 719-9117, as your correspondence is most welcome. Additionally, the physical location of the single location of Sahibzada Afzal MD can be found at the coordinates 34.219607,-118.60808 as well as the street address 22110 Roscoe Boulevard # 301 in Canoga Park, California 91304.
For its online presence, you may visit Sahibzada Afzal MD’s website at and engage with its social media outlets through on Twitter and on Facebook.